Open access peer-reviewed chapter

Spectral and Theoretical Studies of Benzimidazole and 2-Phenyl Substituted Benzimidazoles

Written By

A. Antony Muthu Prabhu

Submitted: 20 October 2021 Reviewed: 10 December 2021 Published: 13 July 2022

DOI: 10.5772/intechopen.101966

From the Edited Volume

Benzimidazole

Edited by Pravin Kendrekar and Vinayak Adimule

Chapter metrics overview

178 Chapter Downloads

View Full Metrics

Abstract

This chapter discusses about the spectral and theoretical aspects of selected benzimidazole and 2-phenyl substituted benzimidazole molecules. The synthesis of these benzimidazoles was reported in many methods by the reaction between o-phenylenediamine with formic acid, aromatic aldehydes and N-benzylbezene-1,2-diamine in presence of oxidant tert-butyl hydroperoxide (TBHP). The spectral analysis of these molecules mainly such as UV-visible, fluorescence in solvents will be included in this chapter and discussed about the absorption, fluorescence maximum, conjugation, transition. Further the optimized structure of these molecules will be given using Gaussian 09 W (DFT 6-31G method). And also will be discussed about structural parameters, highest occupied molecular orbital (HOMO) – lowest unoccupied molecular orbital (LUMO) energy energy values, natural bond orbital (NBO), molecular electrostatic potential map (ESP). Many benzimidazole molecules having tautomers in the structure will be explained with the help of theoretical parameters to describe the structural properties.

Keywords

  • benzimidazole
  • spectral properties
  • computational study
  • NBO
  • MSP

1. Introduction

This chapter will be discussed about the spectral and theoretical studies of benzimidazole and 2-phenyl substituted benzimidazoles. A series of benzimidazole molecules are very important heterocyclic compounds in organic chemistry with two nitrogen atoms in five membered ring fused with aromatic moiety having different nature in spectral and biological properties. Benzimidazoles which contain a hydrogen atom attached to nitrogen in the 1-position readily tautomerize. In this way, many benzimidazole molecules are synthesized from the basic moiety to involving in large applications especially in medicinal fields. This type of benzimidazole derivatives possess the many pharmaceutical properties such as antiviral [1], antitumor [2], antihistaminic [3], antimicrobial [4], antihelminthic [5, 6], anticancer [7], antifungal [8], antimicrobial [4], antibacterial [9], analgesic [10], anti-convulsant [11] and anti-ulcer [12] activity. Some of benzimidazole molecules are used as corrosion inhibitors for metals and alloy surfaces in industrial field [13, 14, 15].

Particularly, Albendazole, Mebendazole and Thiabendazole having benzimidazole moiety are widely used as anthelmintic drugs [16].

Some fluoroquinolones substituted benzimidazole derivatives have been reported by microwave assisted method. The synthesized compounds are reported to be the derivatives of Ciprofloxacin & Norfloxacin [17].

The structural studies of synthesized benzimidazole derivatives are characterized using the spectral techniques such as single crystal XRD, UV-visible, Infrared, 1H NMR, 13C NMR etc. [18, 19, 20, 21]. These main techniques are usually referred for characterizing many organic synthesized molecules to elucidate the presence of functional groups, conjugation and structural parameters. Particularly the absorption and fluorescence spectral properties of these benzimidazole derivatives have been changed with respect to the change in substitution in aromatic ring at o- and p-position [22, 23, 24, 25, 26, 27, 28].

Another important application of benzimidazoles is involved to exhibit the excited state intra-molecular proton transfer reaction (ESIPT) [22, 25, 29, 30, 31]. Particularly, the presence of hydroxyl group in benzimidazole at 2-position in benzene ring is exhibited this process through intramolecular hydrogen bonding between the acidic protons (-OH, -NH2) and basic centers (=N-, -C=O) in same molecule. ESIPT process for benzimidazole molecules is observed through dual fluorescence in aqueous solvent, one a normal stoke shifted fluorescence band and second large stoke shifted fluorescence band. Absorption and emission spectral study of these molecules were reported in different solvents with changing polarity. Moreover, the 2(2′-hydroxyphenyl)benzimidazole molecule are studied the enhancement of ESIPT process in aqueous β-cyclodextrin through the formation of host-guest inclusion complex [32].

The density functional theory (DFT) studies give information regarding the structural parameters, the functional groups, orbital interactions and vibrational frequencies [33]. The DFT calculations with the hybrid exchange-correlation functional B3LYP (Becke’s three parameter (B3) exchange in conjunction with the Lee–Yang–Parr’s (LYP) correlation functional) which are especially important in systems containing extensive electron conjugation and/or electron lone pairs [34, 35, 36]. The HOMO–LUMO energy, MSP map and the Mullikan population analysis will be calculated for the studied molecules. The natural bond orbital (NBO) analysis will explains the most important orbital interactions in order to clarify general structural features. The excited state potential energy surface, excited state intramolecular proton transfer of 2-(2′-Hydroxyphenyl)benzimidazole was investigated by TD-DFT method in gas phase and in solvent [37, 38, 39]. Further the theoretical calculations of Methyl-6-Nitro-1H-Benzimidazole and 1-methyl-2-phenyl benzimidazole was reported [40, 41]. Many benzimidazole molecules were reported theoretically structural properties and vibrational spectra, HOMO-LUMO, NBO analysis by ab initio HF and DFT methods [42, 43, 44, 45]. Theoretical calculations of many benzimidazole molecules in gas phase were analyzed for the structural investigation with the help of experimental results [20, 44, 46, 47, 48, 49].

Advertisement

2. Benzimidazole and 2-phenyl benzimidazoles

The benzimidazole molecule without any substitution was synthesized by the simple reaction between o-phenylenediamine with formic acid in the presence of alkali like sodium hydroxide, potassium hydroxide etc., [50]. The synthesis procedure of benzimidazole is given briefly. 27 g of o-phenylenediamine and 17.5 g of 90% formic acid are taken a 250 ml round bottom flask, the reaction mixture is heated at 100°C on a water bath for 2 hours. After cooling this reaction mixture, the 10% sodium hydroxide solution is added slowly to the solution with constant rotation then the reaction mixture becomes alkaline. Crude benzimidazole is filterd off at the pumb and washed with 25 ml of cold water and the crude product is dissolved in 400 ml of boiling water. Then 2 g of decolourising carbon is added to the solution and heat for 20 minutes. Finally the benzimidazole is formed after filteration at the pumb. New series of benzimidazole and its derivatives were synthesized and characterized using spectral analysis and applied for biological properties [51, 52]. For example, the series of substituted benzimidazole were reported particularly in the 2-position and 1-position replacing the hydrogen atom by both small and large size molecules (Figure 1).

Figure 1.

The reaction shows between o-phenylene diamine with formic acid in presence of sodium hydroxide.

The substituted 2-phenyl benzimidazoles were synthesized from the condensation reaction between o-Phenylenediamine and substituted aromatic aldehydes in chloroform and in the presence of ammonium chloride as a catalyst [53]. This reaction carried out at room temperature using many ammonium salts like ammonium bromide (NH4Br), ammonium chloride (NH4Cl), ammonium fluoride (NH4F), ammonium sulphate ((NH4)2SO4) and ammonium carbonate ((NH4)2CO3). Aromatic aldehydes such as benzaldehyde, m-methyl benzaldehyde, p-methyl benzaldehyde, m-methoxy benzaldehyde, p-methoxy benzaldehyde, o-hydroxy benzaldehyde, p-hydroxy benzaldehyde, o-amino benzaldehyde, p-amino benzaldehyde are used for the preparation of 2-phenyl substituted benzimidazole molecules. 1,2-phenylenediamine is added to the stirred solution of aromatic aldehydes and NH4Cl in CHCl3. This reaction mixture is stirred for 4 hours at room temperature. After completion of the reaction, the phenyl substituted benzimidazoles are formed using Thin layer chromatography, column chromatography (Figure 2).

Figure 2.

The reaction shows between o-phenylene diamine with aromatic aldehyde in chloroform and in presence of ammonium chloride.

Thus 2-phenyl substituted benzimidazole derivative has been reported by another method and the reaction scheme shows in Figure 3. The oxidative dehydrative coupling reaction of N-benzylbenzene-1,2-diamine in the presence of oxidant tert-butyl hydroperoxide (TBHP) in solvent acetonitrile to give substituted 2-phenyl benzimidazoles [54]. N-benzylbenzene1,2-diamine 1.96 g, I2 0.25 g, TBHP 1.8 g, is added in a 25 ml round bottomed flask in acetonitirle solvent and stirred at room temperature. The product is purified by column chromatography and finally the phenyl substituted benzimidazole is formed at the end of reaction.

Figure 3.

Tandem oxidative cyclization of different N-substituted benzene-1,2-diamines.

Advertisement

3. Absorption and emission spectral study

Thus, the molecular diagrams of studied benzimidazole derivatives are shown in Figure 4. In this section, the absorption and emission spectral study is discussed for the selected benzimidazoles in solvents. The absorption and emission maximum was observed at 273 nm, 279 nm and at 291 nm for benzimidazole [55, 56] and at 295 and 350 nm for 2-phenyl benzimidazole [57]. These maximum are similar to 2-(m-methylphenyl)benzimidazole, 2-(p-methylphenyl)benzimidazole, 2-(m-methoxyphenyl)benzimidazole, 2-(p-methoxyphenyl)benzimidazole. But the 2-(o-hydroxyphenyl)benzimidazole molecule is observed the specific property in the ground and excited states to describe the keto-enol tautomeric equilibrium through the excited state intramolecular proton transfer [58, 59, 60, 61, 62, 63, 64, 65], which property already given in introduction part and theoretical study also done for keto-enol tautomer in solvent effect. The absorption maximum of 2-(o-hydroxyphenyl)benzimidazole was observed at 335, 318 and 295 nm and fluorescence maximum at 355 and 465 nm in DMSO [32]. The absorption and emission maximum was observed at 320, 285 and 240 nm and fluorescence maximum at 417 nm in water for 2-(o-aminophenyl)benzimidazole [66] and at 313, 255, and 207 nm and at 382 nm in water for 2-(p-aminophenyl)benzimidazole [67].

Figure 4.

It shows the molecular diagram of selected molecules by DFT B3LYP 6-31G method.

Advertisement

4. Theoretical study

4.1 HOMO-LUMO energy parameters

Initial computational study of selected benzimidazoles has been investigated from the HOMO, LUMO energy diagram in gas phase using DFT B3LYP 6-31G method. The chemical stability of selected benzimidazoles is demonstrated with the help of explaining this energy diagram [68]. Generally, the HOMO energy picture represents the ability to donate an electron and LUMO energy picture represent the ability to obtain an electron. For selected benzimidazoles the electron density is completely localized on the whole ring for both orbitals which shows in Table 1. The higher HOMO-LUMO energy gap of benzimidazole (−5.56 eV) and lower HOMO-LUMO energy gap of 2-(o-aminophenyl)benzimidazole (−4.38 eV) is observed theoretically to describing the stability and reactivity with addition of substitution in the phenyl ring. If the substitution in the benzimidazole is clearly changed the HOMO-LUMO energy gap particularly the amino group at o-position in the phenyl ring with lower value.

Table 1.

HOMO, LUMO energy diagram and molecular electrostatic potential (MSP) diagram obtained by DFT B3LYP 6-31G method.

The theoretical physical parameters of selected benzimidazoles are determined by electronic chemical potential (μ), electronegativity (χ), absolute hardness (η), softness (S) and electrophilicity (ω) values from the HOMO as ionization energy (IE) and LUMO as electron affinity (EA) using the following equations, respectively. These parameters can be calculated using the following Eqs. (1)(5).

μ=EHOMO+ELUMO/2E1
χ=μE2
η=EHOMOELUMO/2E3
S=1/ηE4
ω=μ2/2ηE5

Theoretically calculated absolute hardness and softness are observed in the range from 1.11 to 2.78 eV. The values of μ, χ, η, S, ω for the amino group at o- and p-position leads to lesser values due to the electron donating nature of amino group. Absolute hardness and softness are important properties to measure the molecular stability and reactivity. S has been known as an indicator of the overall stability of a chemical system. A hard molecule has a large energy gap and a soft molecule has a narrow energy gap. Soft molecules are more reactive than hard molecules because they could easily offer electrons to an acceptor. For the simplest transfer of electrons, adsorption could occur at the part of the molecule where softness has the highest magnitude and hardness has the lowest [69]. The absolute hardness and softness of Albendazole molecule (benzimidazole moiety) was reported in the values of 2.56 and 0.39 eV in the gas phase [70]. Further the parameter of electrophilicity index (ω) of a organic molecule gives the information about the binding ability with biomolecules [71, 72, 73].

The calculated dipole moment values of the methoxy substituent at m- and p- are higher than those of other derivatives. But the hydroxyl group at o-position is higher than that of p-position and in amino group at p-position is higher value than that of o-position. The compound that has the highest dipole moment value is 2-(p-methoxyphenyl)benzimidazole with the value of 4.91 D. 2-(p-hydroxyphenyl)benzimidazole has the lowest dipole moment among the studied compounds (1.88 D).

Theoretically calculated energy for selected benzimidazole molecules are investigated with respect to substitution at m- and p-position of methyl, methoxy and also o- and p-position for hydroxyl and amino groups. More negative energy values are observed for 2-(m-methoxyphenyl)benzimidazole and 2-(p-methoxyphenyl)benzimidazole. Further the comparisons of substitutions at m-, p-positions and o-, p-position are not significantly changed in energy values in gas phase. Also thermodynamic parameters such as enthalpy, free energy and entropy are calculated theoretically at room temperature in the gas phase. All values of substituted benzimidazoles are higher than the parent benzimidazole (Table 2).

ParametersBenz imidazole2-phenyl benz imidazole2-(m-methyl phenyl) benz imidazole2-(m-methoxy phenyl) benz imidazole2-(p-methyl phenyl) benz imidazole2-(p-methoxy phenyl) benz imidazole2-(o-hydroxy phenyl) benz imidazole2-(p-hydroxy phenyl) benz imidazole2-(o-amino phenyl) benz imidazole2-(p-amino phenyl) benz imidazole
EHOMO (eV)−6.07−5.84−5.79−5.74−5.73−5.59−5.72−5.62−5.37−5.30
ELUMO (eV)−0.50−1.17−1.12−1.15−0.92−0.98−1.25−1.01−0.99−0.81
EHOMO-ELUMO (eV)−5.56−4.66−4.66−4.59−4.80−4.60−4.47−4.61−4.38−4.49
μ (eV)−3.28−3.50−3.45−3.44−3.32−3.28−3.48−3.31−3.18−3.05
χ (eV)3.283.503.453.443.323.283.483.313.183.05
η (eV)2.782.332.332.292.402.302.232.302.192.24
S (eV)1.391.161.161.141.201.151.111.151.091.12
ω (eV)1.932.622.542.572.292.332.702.372.302.07
μ (Debye)3.613.213.594.053.434.914.071.881.924.33
E (kcal mol−1)−238299.56−383263.72−407929.73−455101.17−407929.73−455102.22−428199.43−430445.47−417989.88−417987.46
G (kcal mol−1)56.89104.71119.60123.60120.89123.44107.09106.93114.97113.24
H (kcal mol−1)80.00133.89152.48155.57152.41155.55137.32136.53145.56144.43
S (kcal mol−1 K−1)77.5397.85110.26107.22105.71107.71101.3999.26102.60104.61

Table 2.

The values of energy of HOMO, LUMO, HOMO-LUMO energy gap, structural parameters, dipole, energy, thermodynamic parameters of selected benzimidazoles obtained by DFT B3LYP 6-31G method.

4.2 Molecular electrostatic potential

Another investigating theoretical study is molecular electrostatic potential map (MSP) and displayed in Table 1. The electrophiles tend to negative ESP and the nucleophiles tend to region of positive ESP. The molecular electrostatic potential was calculated with DFT B3LYP 6-31G level of theory. The negative regions (red) are mainly contained on the nitrogen atom (=N-) and oxygen atom from methoxy, hydroxyl groups while the positive regions (blue) for the proton from –N-H, -OCH3, -OH and -NH2 group.

4.3 Natural bond orbital (NBO) analysis

Further to study of the intramolecular interactions of selected benzimidazoles, the theoretical NBO is used to calculate the stabilization energy for -C-H, -N-H and lone pair electrons in heteroatoms using second-order perturbation theory [74]. Some calculations about NBO analysis for investigating the intra and intermolecular interactions of isolated organic molecules and inclusion complexes between organic molecules and cyclodextrins [75, 76] were reported theoretically. NBO 3.1 program is applied to perform the natural bond orbital (NBO) analysis [77, 78] in the Gaussian 09 W package at the DFT/B3LYP level. In this work, DFT B3LYP 6-31G method is applied to analysis of intramolecular interactions for selected benzimidazoles. The stabilization energy E(2) for the donor and acceptor orbital delocalization is involved through the occupied Lewis-type (bond or lone pair) NBOs and formally unoccupied (antibond or Rydberg) non-Lewis NBOs within the molecules [79, 80]. The electron density of all atoms is noted in the selected benzimidazole molecules.

The second-order Fock matrix is carry out to evaluate the donor–acceptor interactions within the molecules to specify in conjugative π bonds and lone pair electrons through the NBO analysis [81]. The Eq. (6) is given below to estimate the stabilization energy E(2) for the donor and acceptor orbital delocalization within the molecule.

E2=ΔEij=qiFij2εjεiE6

where qi is the donor orbital occupancy, εi and εj are diagonal elements (orbital energies), and F(i, j) is the off-diagonal NBO Fock matrix element [82, 83, 84]. This analysis reveals that the conjugative interaction, hyper-conjugative interaction, intra and intermolecular hydrogen bond in the same molecules and combine with other molecules are well described for the donor – acceptor orbitals.

Thus the interaction between π(N11-C12) and π*(C4-C7) are reveals the hyperconjugative energy about 19.04, 20.00, 20.05, 19.99, 20.10, 20.13, 19.41, 20.11, 19.96, and 20.30 kJ/mol for selected benzimidazole and 2-phenyl benzimidazoles respectively. This interaction could be revealed that the delocalization occurs in five membered ring for benzimidazole, due to the presence of C=N-C. Similarly the conjugative π bonds in the phenyl ring shows maximum delocalization during the interaction with π* acceptor bonds. It is evident from benzimidazoles that the πC2-C5, C3-C6 and C4-C7 delocalize more energy to the acceptor bond (π* acceptor). The electron density of donor bonds decreases while the acceptor (π*) bond electron density increases. Investigation of NBO analysis is described the stabilization energy for the conjugative interaction or charge transfer between the donor and acceptor bond orbitals [85, 86]. The interactions of π(C-C) with π*(C-C), π*(N-C) and π(N-C) with π*(C-C) are more responsible for the conjugation of respective π* bonds in benzimidazole and substituted 2-phenyl benzimidazole. The investigated molecules are divided into parts from the results of NBO analysis. One part is benzimidazole moiety and other benzene ring without and with substitutions. From the Table 3 these conjugative interactions are formed with close stabilization energy in the range from 17.00 to 23.00 kcal/mol. The stabilization energy values for these interactions are agreed with literature values [87]. From the Table 3, the π*(N11-C12) delocalizes the maximum energy to π(C4-C7) and (C15-C18) bond respectively for all benzimidazoles in the range from 54.62 to 190.30 kJ/mol. Similarly, the π*(C18-C19) bond transfers the high energy about 247.57 kJ/mol to (C16-C20) bond for 2-(o-hydroxyphenyl)benzimidazole. The second order perturbation energies associated with the hyperconjugative interactions in NBO basis confirms the presence of intermolecular interactions.

Donor (i)Acceptor (j)Benz imidazole2-phenyl benz imidazole2-(m-methyl phenyl) benz imidazole2-(m-methoxy phenyl) benz imidazole2-(p-methyl phenyl) benz imidazole2-(p-methoxy phenyl) benz imidazole2-(o-hydroxy phenyl) benz imidazole2-(p-hydroxy phenyl) benz imidazole2-(o-amino phenyl) benz imidazole2-(p-amino phenyl) benz imidazole
E(2) kJ mol−1
π(C2-C5)π*(C3-C6)22.2922.1222.1122.1522.0722.0722.0418.1421.8921.97
π *(C4-C7)17.7317.8317.8217.8617.8217.8518.4420.1518.1117.82
π(C3-C6)π*(C2-C5)18.0318.0918.0918.0718.1018.0918.3222.0218.3218.12
π*(C4-C7)20.1320.2220.1820.2020.1520.1320.6617.8720.2720.03
π(C4-C7)π*(C2-C5)18.4918.3618.3918.3618.4018.4218.1318.1918.3518.48
π*(C3-C6)18.0418.0418.0918.0918.1418.2017.8918.4018.1818.35
π*(N11-C12)18.5716.7316.6316.6316.5916.5215.8716.5316.0416.26
π(N11-C12)π*(C4-C7)19.0420.0020.0519.9920.1020.1319.4120.1119.9620.30
π*(C15-C18)10.129.907.869.909.786.71
π(C15-C18)π*(N11-C12)20.6019.9719.3421.0220.8524.9421.7521.30
π*(C16-C19)19.8021.1120.9318.4517.8315.7118.0217.24
π*(C17-C20)19.1618.7019.7719.7720.3322.7423.4921.91
π(C16-C19)π*(C15-C18)20.4819.6619.5922.0220.8823.9322.4922.5922.66
π*(C17-C20)19.2720.4622.9718.2016.3219.1817.8018.1716.42
π(C17-C20)π*(C15-C18)20.5521.1620.0719.6618.7616.5017.2216.4117.22
π*(C16-C19)21.8420.4917.0423.6223.3821.2422.9522.3623.69
LP(1)N11π*(C4-C7)6.9533.8333.78
π*(C12-N13)8.2852.8149.09
LP(1)N13π*(C4-C7)33.9633.9633.8233.9133.7934.0333.76
π*(N11-C12)49.0749.0048.7249.0648.9251.1348.93
LP(1)O25π*(C18-C19)31.7934.8230.14
π*(N11-C12)π*(C4-C7)54.6278.6579.2377.7277.9850.2475.9862.7680.03
π*(C15-C18)167.75152.81100.02166.29190.3984.58148.0277.69174.06
π*(C18-C19)π*(C15-C17)151.75
π*(C16-C20)166.50168.46247.57272.37

Table 3.

Second order perturbation theory analysis of Fock matrix in NBO basis for selected benzimidazoles by DFT B3LYP 6-31G method.

4.4 Mulliken atomic charges

Thus the important quantum mechanical calculations further applied to calculate the atomic charges for molecular system [88]. The charge distributions of all atoms present in benzimidazole molecules are calculated by the Mulliken method [89]. The Mulliken atomic charges of selected benzimidazole molecules are presented in Table 4 and shown in Figure 5. The Mulliken atomic charges were computed at the DFT B3LYP 6-31G method. The carbon atoms numbering C4, C7 and C12 are shown with the positive values except other carbon atoms in the whole system. These results expected that these carbon atoms are connected with electronegative nitrogen atoms in benzimidazole [90]. In benzimidazole, C7 atom is bonded with N13-H having high positive value (0.329 a.u.) and C4 atom with N11 atom having less positive value (0.032 a.u.). The other benzimidazole molecules are following the same trend. A positive charge of all the hydrogen atoms are displayed in Table 4, but H26 was gained maximum positive charge than the other hydrogen atoms, due to the presence of electronegative atom (O25) in o-hydroxy and p-hydroxyphenyl benzimidazole when compared with the hydrogen in amino group lesser values. The presence of three nitrogen atoms in o-amino and p-aminophenyl benzimidazole (N11 = −0.481 a.u., N13 = −0.804 a.u. and N25 = −0.721 a.u.) are shown in different environment because N13 atom more negative values.

AtomsBenz imidazole2-phenyl benz imidazole2-(m-methyl phenyl) benz imidazole2-(m-methoxy phenyl) benz imidazole2-(p-methyl phenyl) benz imidazole2-(p-methoxy phenyl) benz imidazole2-(o-hydroxy phenyl) benz imidazole2-(p-hydroxy phenyl) benz imidazole2-(o-amino phenyl) benz imidazole2-(p-amino phenyl) benz imidazole
1H0.1382610.1371000.1367820.1376550.1361210.1359580.1418450.1261520.1347020.133829
2 C−0.097181−0.106860−0.107260−0.107084−0.107632−0.108005−0.097640−0.074372−0.106858−0.109524
3 C−0.066378−0.073803−0.073798−0.073607−0.074250−0.074668−0.073868−0.108222−0.073166−0.075092
4 C0.0329160.0713220.0701490.0680020.0717520.0715100.1103150.0722850.0792840.070580
5 C−0.136317−0.134176−0.134219−0.134114−0.134392−0.134414−0.135183−0.155754−0.134554−0.134574
6 C−0.156456−0.155168−0.155464−0.155447−0.155462−0.155708−0.152607−0.134226−0.155256−0.156420
7 C0.32960180.33652980.3359070.3346650.3360730.3356540.3249240.3357760.3336720.334464
8H0.12292290.1220710.1215650.1222170.1210820.1206840.1266770.1207360.1226880.118882
9H0.122542100.121868100.1212940.1217220.1207970.1202050.1325160.1208660.1226010.118473
10H /N0.127474110.127019110.1264260.1260320.1260640.125161−0.5605860.1352510.1291380.123999
11 N /C−0.40539712−0.43623112−0.435362−0.431475−0.437937−0.4386200.430471−0.829967−0.481336−0.440923
12C/N/H0.257366130.359609130.3555410.3506130.3589570.359337−0.8257230.3217070.3710330.357256
13 N/H/C−0.76618814−0.82816914−0.825954−0.822124−0.829186−0.8294670.3301130.359544−0.804057−0.827406
14H/C/N0.320980150.322653150.3221420.3200840.3218830.3203760.187442−0.4414480.3249860.319629
15H0.175857
15C0.136898160.1358170.1256870.1412600.137938−0.1182260.1383960.1249730.130048
16C−0.11274417−0.137633−0.1205740.1065750.287632−0.1699220.258006−0.1147790.237503
17C−0.14206118−0.141589−0.140008−0.147270−0.1423650.174685−0.1540650.191570−0.146137
18C−0.14786719−0.169322−0.155106−0.152066−0.156250−0.112405−0.149417−0.160741−0.152654
19C−0.136766200.0909060.265929−0.159726−0.145257−0.137129−0.149145−0.141445−0.144521
20C /H−0.13440521−0.135466−0.132738−0.157269−0.1410350.147321−0.119925−0.144329−0.143119
21H0.171517220.1676010.1652970.1698630.1731900.1234460.1146750.1215860.169114
22H0.109434230.1048340.1152600.1077990.1118100.1321890.1753350.1201840.109992
23H0.128863240.1309580.1348360.1249760.1311910.1274310.1287660.1228460.117131
24H0.133428250.1247600.1416720.1296450.1454110.1108200.1443320.1267610.122272
25H/C/O/N0.129940−0.481792−0.546460−0.471062−0.541636−0.613107−0.607400−0.721965−0.721135
26H/C0.161815−0.1729630.159713−0.1758960.3961960.3721130.2849140.293247
27H0.1486390.1494000.1479090.1491360.3275500.295088
28H0.1427230.1701470.1457820.169412
29H0.1424820.148717

Table 4.

The computed Mulliken atomic charges for selected benzimidazole molecules given using DFT B3LYP 6-31G method.

Figure 5.

The computed Mulliken charges for all atoms in selected benzimidazoles.

Advertisement

5. Conclusion

Ten compounds of benzimidazole and 2-phenyl substituted benzimidazoles such as (1) benzimidazole, (2) 2-phenylbenzimidazole, (3) 2-(m-methylphenyl)benzimidazole, (4) 2-(p-methylphenyl)benzimidazole, (5) 2-(m-methoxyphenyl)benzimidazole, (6) 2-(p-methoxyphenyl)benzimidazole, (7) 2-(o-hydroxyphenyl)benzimidazole, (8) 2-(p-hydroxyphenyl)benzimidazole, (9) 2-(o-aminophenyl)benzimidazole and (10) 2-(p-aminophenyl)benzimidazole were selected to study for the spectral and theoretical properties. Synthesis of these molecules by many methods were discussed and given the reaction scheme. Then the absorption and fluorescence spectrum of all molecules were given with changing the wavelength respect to the substitution of groups in the benzene ring. The conjugation and maximum also involved and π-π* transition possible in the absorption spectrum. Further, DFT method was used to determine the structural parameters, energy values, HOMO-LUMO energy gap, thermodynamic parameters, molecular electrostatic potential map for all molecules. NBO analysis was revealed the hyperconjugative interaction between bonding orbitals, lone pair orbitals and antibonding orbitals and also calculated the stabilization energy of selected bonded orbitals. Finally the computed Mulliken atomic charges was determined using DFT B3LYP 6-31G method.

References

  1. 1. Tonelli M, Simone M, Tasso B, Novelli F, Boido V, Sparatore F, et al. Activiral activity of benzimidazole derivatives. II. Activiral activity of 2-phenylbenzimidazole derivatives. Bioorganic & Medicinal Chemistry. 2010;18:2937-2953. DOI: 10.1016/j.bmc.2010.02.037
  2. 2. Mann J, Baron A, Opoku-Boahen Y, Johansson E, Parkinson G, Kelland LR, et al. A new class of symmetric bisbenzimidazole-based DNA minor groove-binding agents showing antitumor activity. Journal of Medicinal Chemistry. 2001;44:138-144. DOI: 10.1021/jm000297b
  3. 3. Iemura R, Hori M, Saito T, Ohtaka H. Bioisosteric transformation of H1-antihistaminic benzimidazole derivatives. Chemical & Pharmaceutical Bulletin. 1989;37:2723-2726. DOI: 10.1248/cpb.37.2723
  4. 4. Ansari KF, Lal C. Synthesis, physicochemical properties and antimicrobial activity of some new benzimidazole derivatives. European Journal of Medicinal Chemistry. 2009;44:4028-4033. DOI: 10.1016/j.ejmech.2009.04.037
  5. 5. Preston PN. Synthesis, reactions and spectroscopic properties of benzimidazoles. Chemical Reviews. 1974;74:279-314. DOI: 10.1021/cr60289a001
  6. 6. Márquez-Navarro A, Nogueda-Torresa B, Hernández-Campos A, Soria-Artechec O, Castillo R, Rodríguez-Morales S, et al. Anthelmintic activity of benzimidazole derivatives against Toxocara canis second-stage larvae and Hymenolepis nana adults. Acta Tropica. 2009;109:232-235. DOI: 10.1016/j.actatropica.2008.11.014
  7. 7. Refaat HM. Synthesis and anticancer activity of some novel 2-substituted benzimidazole derivatives. European Journal of Medicinal Chemistry. 2010;45:2949-2956. DOI: 10.1016/j.ejmech.2010.03.022
  8. 8. Sharma S, Gangal S, Rauf A. Convenient one-pot synthesis of novel 2-substitutedbenzimidazoles, tetrahydrobenzimidazoles and imidazoles and evaluation oftheir in vitro antibacterial and antifungal activities. European Journal of Medicinal Chemistry. 2009;44:1751-1757. DOI: 10.1016/j.ejmech.2008.03.026
  9. 9. Zhang D, Wang Z, Xu W, Sun F, Tang L, Wang J. Design, synthesis and antibacterial activity of novel actinonin derivatives containing benzimidazole heterocycles. European Journal of Medicinal Chemistry. 2009;44:2202-2210. DOI: 10.1016/j.ejmech.2008.05.009
  10. 10. Kaplancikli ZA, Turan-Zitouni G, Ozdemir A, Can Ozgur D, Chevallet P. Synthesis and Antinociceptive Activities of Some Pyrazoline Derivatives. European Journal of Medicinal Chemistry. 2009;44:2606-2610. DOI: 10.1007/s00044-014-1309-1
  11. 11. Sahoo BM, Banik BK, Mazaharunnisa RNS, Raju B. Microwave assisted green synthesis of benzimidazole derivatives and evaluation of their anticonvulsant activity. Current Microwave Chemistry. 2019;6:23-29. DOI: 10.2174/2213335606666190429124745
  12. 12. Patil A, Ganguli S, Surana S. Synthesis And Antiulcer Activity Of 2-[5-Substituted-1-H-Benzo(D)Imidazole-2-Yl Sulfinyl] Methyl-3-Substituted Quinqzoline-4-(3H)Ones. Journal of Chemical Sciences. 2010;3(122):443-449. DOI: 10.1007/s12039-010-0052-5
  13. 13. Aljourani J, Golozar MA, Raessi K. The inhibition of carbon steel corrosion in hydrochloric and sulfuric acid media using some benzimidazole derivatives. Materials Chemistry and Physics. 2010;121:320-325. DOI: 10.1016/j.matchemphys.2010.01.040
  14. 14. Obot IB, Obi-Egbedi NO. Theoretical study of benzimidazole and its derivatives and their potential activity as corrosion inhibitors. Corrosion Science. 2010;52:657-660. DOI: 10.1016/j.corsci.2009.10.017
  15. 15. Dutta A, Saha S, Adhikari U, Banerjee P, Sukul D. Effect of substitution on corrosion inhibition properties of 2-(substituted phenyl) benzimidazole derivatives on mild steel in 1M HCl solution: A combined experimental and theoretical approach. Corrosion Science. 2017;123:256-266. DOI: 10.1016/j.corsci.2017.04.017
  16. 16. Kohler P. The biochemical basis of anthelmintic action and resistance. International Journal for Parasitology. 2001;31:336-345. DOI: 10.1016/s0020-7519(01)00131-x
  17. 17. Jubie S, Rajeshkumar R, Yella Reddy B, Siddhartha G, Sandeep M, Surendrareddy K, et al. Microwave assisted synthesis of some novel Benzimidazole submitted fluoroquinolones and their antimicrobial evaluation. Journal of Pharmaceutical Sciences and Research. 2010;2:69-76
  18. 18. Bai Y, Lv X, Liu Z, Guo T, Li J. Synthesis, spectral and DFT study of 5-butyl-3,9-difluoro-5H-benzimidazo[1,2-a] Benzimidazole. Journal of Molecular Structure. 2018;115:111-125. DOI: 10.1016/j.molstruc.2017.08.102
  19. 19. Akkoç S, Tüzün B, İlhan IO, Akkurt M. Investigation of structural, spectral, electronic, and biological properties of 1,3-disubstituted benzimidazole derivatives. Journal of Molecular Structure. 2020;1219:128582-128592. DOI: 10.1016/j.molstruc.2020.128593
  20. 20. Nour T, Ghani A, Mansour AM. Molecular structure of 2-chloromethyl-1H-benzimidazole hydrochloride: Single crystal, spectral, biological studies, and DFT calculations. Spectrochimica Acta A. 2012;86:605-613. DOI: 10.1016/j.saa.2011.11.024
  21. 21. Li GY, Geng JC, He CH, Cui GH. Structure, spectroscopy, and theory calculations on 1,3-bis((5,6-dimethyl-1H-benzo[d]imidazol-1-yl)methyl)benzene. Journal of Molecular Structure. 2013;1031:56-60. DOI: 10.1016/j.molstruc.2012.07.014
  22. 22. Patil VS, Padalkar VS, Tathe AB, Gupta VD, Sekar N. Synthesis, Photo-physical and DFT Studies of ESIPT Inspired Novel 2-(2′,4′-Dihydroxyphenyl) Benzimidazole, Benzoxazole and Benzothiazole. Journal of Fluorescence. 2013;23:1019-1029. DOI: 10.1007/s10895-013-1228-4
  23. 23. Sinha H, Dogra S. Ground and excited state prototropic reactions in 2-(o-hydroxyphenyl) benzimidazole. Chemical Physics. 1986;102:337-347. DOI: 10.1016/0301-0104(86)80006-4
  24. 24. Douhal A, Amat-Guerri F, Lillo M, Acuna A. Proton transfer spectroscopy of 2-(2′-hydroxyphenyl) imidazole and 2-(2′-hydroxyphenyl) benzimidazole dyes. Journal of Photochemistry and Photobiology A: Chemistry. 1994;78:127-138. DOI: 10.1016/1010-6030(93)03724-U
  25. 25. Padalkar VS, Tathe AB, Gupta VD, Patil VS, Phatangare KR, Sekar N. Synthesis and photo-physical characteristics of ESIPT inspired 2-substituted benzimidazole, benzoxazole and benzothiazole fluorescent derivatives. Journal of Fluorescence. 2012;22:311-322. DOI: 10.1007/s10895-011-0962-8
  26. 26. Sandra S, Dogra S. Excited state intramolecular protons transfer in 2-(2′-N-palmitoyl-aminophenyl) benzimidazole: Effect of carbonyl group. Journal of Molecular Structure. 1999;476:223-233. DOI: 10.1016/S0022-2860(98)00550-X
  27. 27. Manojai N, Daengngern R, Kerdpol K, Ngaojampa C, Kungwan N. Heteroatom effect on photophysical properties of 2-(2′-hydroxyphenyl) benzimidazole and its derivatives as fluorescent dyes: A TD-DFT study. Journal of Luminescence. 2017;188:275-282. DOI: 10.1016/j.jlumin.2017.04.040
  28. 28. Al-Jorani KR, Abbas RF, Waheb AA. Synthesis and characterization of a novel benzimidazole derivative: Solvatochromic and acid-base indicator applications. Materials Today: Proceedings. 2021;42:1791-1799. DOI: 10.1016/j.matpr.2020.12.184
  29. 29. Vazquez SR, Rodriguez MCR, Mosquera M. Rotamerism, tautomerism, and excited-state intramolecular proton transfer in 2-(4′-N, N-diethylamino-2′- hydroxyphenyl)benzimidazoles: Novel benzimidazoles undergoing excited-state intramolecular coupled proton and charge transfer. The Journal of Physical Chemistry. A. 2008;112:376-387. DOI: 10.1021/jp076634a
  30. 30. Henary MM, Wu Y, John Cody S, Sumalekshmy S, Li J, Mandal S, et al. Excited-state intramolecular proton transfer in 2-(2’-Arylsulfonamidophenyl)benzimidazole derivatives: The effect of donor and acceptor substituents. The Journal of Organic Chemistry. 2007;72:4784-4797. DOI: 10.1021/jo070433l
  31. 31. Santra S, Dogra SK. Excited-state intramolecular proton transfer in 2-(2′-Aminophenyl)benzimidazole. Chemical Physics. 1998;226:285-296. DOI: 10.1016/S0301-0104(97)00311-X
  32. 32. Chipem FAS, Behera SK, Krishnamoorthy G. Enhancing excited state intramolecular proton transfer in 2-(2′-Hydroxyphenyl)benzimidazole and its nitrogen-substituted analogues by β-Cyclodextrin: The effect of nitrogen substitution. The Journal of Physical Chemistry. A. 2013;117:4084-4095. DOI: 10.1021/jp311438s
  33. 33. Golcuk K, Altun A, Kumru M. Thermal studies and vibrational analyses of m-methylaniline complexes of Zn(II), Cd(II) and Hg(II)bromides. Spectrochimica Acta A. 2003;59:1841-1847. DOI: 10.1016/S1386-1425(02)00415-8
  34. 34. Vaschetto ME, Retamal BA, Monkman AP. Density functional studies of aniline and substituted anilines. Journal of Molecular Structure: THEOCHEM. 1999;468:209-221. DOI: 10.1016/S0166-1280(98)00624-1
  35. 35. Clark T, Chandrasekhar J, Spitznagel GW, Schleyer PVR. Efficient diffuse function-augmented basis sets for anion calculations. III. The 3-21+G basis set for first-row elements, Li-F. Journal of Computational Chemistry. 1983;4:294-301. DOI: 10.1002/jcc.540040303
  36. 36. Forsyth DA, Sebag AB. Computed 13C NMR chemical shifts via empirically scaled GIAO shielding and molecular mechanics geometries. Conformation and configuration from 13C shifts. Journal of the American Chemical Society. 1997;119:9483-9494. DOI: 10.1021/ja970112z
  37. 37. Gavin Tsai HH, Sara Sun HH, Tan CJ. TD-DFT Study of the Excited-State Potential Energy Surfaces of 2-(2′-Hydroxyphenyl)benzimidazole and its amino derivatives. The Journal of Physical Chemistry. A. 2010;114:4065-4079. DOI: 10.1021/jp100022y
  38. 38. Chipem FAS, Dash N, Krishnamoorthy G. Role of nitrogen substitution in phenyl ring on excited state intramolecular proton transfer and rotamerism of 2-(2′-Hydroxyphenyl)-benzimidazole: A theoretical study. The Journal of Chemical Physics. 2011;134:1-9. DOI: 10.1063/1.3562124
  39. 39. Prommin C, Kanlayakan N, Chansen W, Salaeh R, Kerdpol K, Daengngern R, et al. Theoretical insights on solvent control of intramolecular and intermolecular proton transfer of 2-(2’-Hydroxyphenyl)benzimidazole. The Journal of Physical Chemistry. A. 2017;121:5773-5784. DOI: 10.1021/acs.jpca.7b03454
  40. 40. Oturak H, Kınaytürk NK, Çırak C. Experimental and theoretical spectral (FT-IR, Raman, NMR, UV-Vis and NLO) analysis of a potential antitumor drug: 1-Methyl-6-Nitro-1H-benzimidazole. Spectroscopy and Spectal Analysis. 2018;38:1963-1969. DOI: 10.3964/j.ssn.1000-0593(2018)06-1963-07
  41. 41. Karnan M, Balachandran V, Murugan M, Murali MK. Quantum chemical vibrational study, molecular property, FTIR, FT-Raman spectra, NBO, HOMO-LUMO energies and thermodynamic properties of 1-methyl-2-phenyl benzimidazole. Spectrochimica Acta A. 2014;130:143-151. DOI: 10.1016/j.saa.2014.03.128
  42. 42. Mary YS, Jojo PJ, Panicker CY, Alsenoy CV, Ataei S, Yildiz I. Theoretical investigations on the molecular structure, vibrational spectra, HOMO-LUMO and NBO analysis of 5-chloro-2-((4-chlorophenoxy) methyl) benzimidazole. Spectrochimica Acta A. 2014;122:499-511. DOI: 10.1016/j.saa.2013.11.025
  43. 43. Sundaraganesan N, Ilakiamani S, Subramani P, Joshua BD. Comparison of experimental and ab initio HF and DFT vibrational spectra of benzimidazole. Spectrochimica Acta A. 2007;67:628-635. DOI: 10.1016/j.saa.2006.08.020
  44. 44. Sekerci M, Atalay Y, Yakuphanoğlu F, Başoğlu DA. A theoretical study on 1-(thiophen-2-yl-methyl)-2-(thiophen-2-yl)-1H-benzimidazole. Spectrochimica Acta A. 2007;67:503-508. DOI: 10.1016/j.saa.2006.08.007
  45. 45. Xavier TS, Rashid N, Joe IH. Vibrational spectra and DFT study of anticancer active molecule 2-(4-Bromophenyl)-1H-benzimidazole by normal coordinate analysis. Spectrochimica Acta A. 2011;78:319-326. DOI: 10.1016/j.saa.2010.10.013
  46. 46. Foujji LE, Bourakadi KE, Essassi EM, Boeré RT, Qaiss A, Bouhfid R. Solid-state zwitterionic tautomerization of 2-((5-methyl-1H-pyrazol-3-yl)methyl)-1H-benzimidazole: Synthesis, characterization, DFT calculation and docking studies. Journal of Molecular Structure. 2021;1235:130231-130241. DOI: 10.1016/j.molstruc.2021.130231
  47. 47. Nour T, Ghani A, Mansour AM. Molecular structures of 2-arylaminomethyl-1H-benzimidazole: Spectral, electrochemical, DFT and biological studies. Spectrochimica Acta A. 2012;91:272-284. DOI: 10.1016/j.saa.2012.01.080
  48. 48. Unal A, Eren B. FT-IR, dispersive Raman, NMR, DFT and antimicrobial activity studies on 2-(Thiophen-2-yl)-1H-benzo[d]imidazole. Spectrochimica Acta A. 2013;114:129-136. DOI: 10.1016/j.saa.2013.05.045
  49. 49. Nour T, Ghani A, Mansour AM. 2-[(1H-Benzimidazol-2-ylmethyl)-amino]-benzoic acid methyl ester: Crystal structure, DFT calculations and biological activity evaluation. Spectrochimica Acta A. 2011;81:754-763. DOI: 10.1016/j.saa.2011.07.021
  50. 50. Furniss BS, Hannaford AJ, Smith PWG, Tatchell AR, Vogel’s. Textbook of Practical Organic Chemistry. 5th ed. New York: John Wiley & Sons; 1989. p. 1162. DOI: 10.1002/pola.1991.080290821
  51. 51. El-Gohary NS, Shaaban MI. Synthesis and biological evaluation of a new series of benzimidazole derivatives as antimicrobial, antiquorum-sensing and antitumor agents. European Journal of Medicinal Chemistry. 2017;131:255-262. DOI: 10.1016/j.ejmech.2017.03.018
  52. 52. Adegboye AA, Khan KM, Salar U, Aboaba SA, Kanwal CS, Fatima I, et al. 2-Aryl benzimidazoles: Synthesis, In vitro α-amylase inhibitory activity, and molecular docking study. European Journal of Medicinal Chemistry. 2018;150:248-260. DOI: 10.1016/j.ejmech.2018.03.011
  53. 53. Nannapaneni DT, Gupta Atyam VSSS, Reddy MI, Sarva Raidu C. Synthesis, characterization, and biological evaluation of benzimidazole derivatives as potential anxiolytics. Journal of Young Pharmacists. 2010;2(3):273-279. DOI: 10.4103/0975-1483.66809
  54. 54. Patil SV, Patil SS, Bobade VD. A simple and efficient approach to the synthesis of 2-substituted benzimidazole via sp3 C–H functionalization. Arabian Journal of Chemistry. 2016;9:S515-S521. DOI: 10.1016/j.arabjc.2011.06.017
  55. 55. Hoffman K. The Chemistry of Heterocyclic Compounds. Imidazole and Its Derivatives, Part I, Interscience. New York: Wiley; 1951
  56. 56. Tway PC, Cline Love LJ. Photophysical properties of benzimidazole and thiabendazole and their homologues. Effect of substituents and solvent on the nature of the transition. The Journal of Physical Chemistry. 1982;86:5223-5226. DOI: 10.1021/j100223a031
  57. 57. Mishra AK, Dogra SK. Effect of solvents and pH on the absorption and fluorescence spectra of 2-phenylbenzimidazole. Spectrochimica Acta A. 1983;39:609-611. DOI: 10.1016/0584-8539(83)80033-6
  58. 58. Roberts EL, Dey J, Warner IM. Ground- and excited-state structural orientation of 2-(2’-Hydroxyphenyl)benzazoles in cyclodextrins. The Journal of Physical Chemistry. 1996;100:19681-19686. DOI: 10.1021/jp961500a
  59. 59. Roberts EL, Dey J, Warner IM. Excited-state intramolecular proton transfer of 2-(2’-hydroxyphenyl)benzimidazole in cyclodextrins and binary solvent mixtures. The Journal of Physical Chemistry. A. 1997;101:5296-5301. DOI: 10.1021/jp971232w
  60. 60. Fores M, Duran M, Sola M, Orozco M, Luque FJ. Theoretical evaluation of solvent effects on the conformational and tautomeric equilibria of 2-(2’-Hydroxyphenyl)benzimidazole and on its absorption and fluorescence spectra. The Journal of Physical Chemistry. A. 1999;103:4525-4532. DOI: 10.1021/jp984773+
  61. 61. Chipem FAS, Krishnamoorthy G. Comparative theoretical study of rotamerism and excited state intramolecular proton transfer of 2-(2′-Hydroxyphenyl)benzimidazole, 2-(2′-hydroxyphenyl)imidazo[4,5-b]pyridine, 2-(2′-Hydroxyphenyl)imidazo[4,5-c] pyridine and 8-(2′-Hydroxyphenyl)purine. The Journal of Physical Chemistry. A. 2009;113:12063-12070. DOI: 10.1021/jp903535g
  62. 62. Sahu S, Das M, Krishnamoorthy G. Switching between CIS and trans anions of 2-(2′-hydroxyphenyl)benzimidazole: A molecular rotation perturbed by chemical stabilization. Physical Chemistry Chemical Physics. 2016;18:11081-11090. DOI: 10.1039/C5CP07949G
  63. 63. Vázquez SR, Lustres JLP, Rodríguez-Prieto F, Mosquera M, Ríos Rodríguez MC. Excited-state proton and charge transfer in protonated amino and methylated derivatives of 2-(2′-hydroxyphenyl)benzimidazole. The Journal of Physical Chemistry. B. 2015;119:2475-2489. DOI: 10.1021/jp507917u
  64. 64. Behera SK, Sadhuragiri G, Elumalai P, Sathiyendiran M, Krishnamoorthy G. Exclusive excited state intramolecular proton transfer from a 2-(2′-hydroxyphenyl)benzimidazole derivative. RSC Advances. 2016;6:59708-59717. DOI: 10.1039/C6RA11780E
  65. 65. Akutsu K, Mori S, Shinmei K, Iwase H, Nakano Y, Fujii Y. Investigation of substitution effect on fluorescence properties of Zn2+-selective ratiometric fluorescent compounds: 2-(2′-Hydroxyphenyl)benzimidazole derivatives. Talanta. 2016;146:575-584. DOI: 10.1016/j.talanta.2015.09.001
  66. 66. Mishra AK, Dogra SK. Photoluminescence of 2-(o-aminophenyl)benzimidazole. Journal of Photochemistry. 1985;31:333-344. DOI: 10.1016/0047-2670(85)85101-7
  67. 67. Mishra AK, Dogra SK. Effects of solvents and pH on the spectral behavior of 2-(p-aminophenyl)benzimidazole. Bulletin of the Chemical Society of Japan. 1985;58:3587-3592. DOI: 10.1246/bcsj.58.3587
  68. 68. Fleming I. Frontier Orbitals and Organic Chemical Reactions. New York: John Wiley & Sons; 1976
  69. 69. Mansour AM. Molecular structure and spectroscopic properties of novel manganese(II)complex with sulfamethazine drug. Journal of Molecular Structure. 2013;1035:114-123. DOI: 10.1016/j.molstruc.2012.09.048
  70. 70. Nora M, Fatiha M, Leila N, Sakina H, Eddine KD. Density functional study of inclusion complex of albendazole/cucurbit[7]uril: Structure, electronic properties, NBO, GIAO and TD-DFT analysis. Journal of Molecular Liquids. 2015;211:40-47. DOI: 10.1016/j.molliq.2015.06.054
  71. 71. Alyar S, Tülin S. Synthesis, spectroscopic characterizations, enzyme inhibition , molecular docking study and DFT calculations of new Schiff bases of sulfa drugs. Journal of Molecular Structure. 2019;1185:416-424. DOI: 10.1016/j.molstruc.2019.03.002
  72. 72. Mondal S, Mandal SM, Mondal TK, Sinha C. Structural characterization of new Schiff bases of sulfamethoxazole and sulfathiazole, their antibacterial activity and docking computation with DHPS protein structure. Spectrochimica Acta A. 2015;150:268-279. DOI: 10.1016/j.saa.2015.05.049
  73. 73. Banuppriya G, Sribalan R, Padmini V. Synthesis and characterization of curcumin-sulfonamide hybrids: Biological evaluation and molecular docking studies. Journal of Molecular Structure. 2018;1155:90-100. DOI: 10.1016/j.molstruc.2017.10.097
  74. 74. Glendening ED, Reed AE, Carpenter JE, Weinhold F. NBO Version 3.1. Pittsburgh: Gaussian Inc.; 2003
  75. 75. Antony Muthu Prabhu A, Suresh Kumar GS, Fatiha M, Sorimuthu S, Sundar RM. Encapsulation of phenylalanine and 3,4-dihydroxyphenylalanine into β-cyclodextrin: Spectral and molecular modeling studies. Journal of Molecular Structure. 2015;1079:370-382. DOI: 10.1016/j.molstruc.2014.08.045
  76. 76. Antony Muthu Prabhu A, Fatiha M, Leila N, Anantha Raj T, Navarro-Gonzalez I, Periago MJ, et al. Investigation of 3D contour map and intermolecular interaction of dopamine with β-Cyclodextrin and 2-hydroxypropyl-β-cyclodextrin. Journal of Solution Chemistry. 2018;47:409-429. DOI: 10.1007/s10953-018-0728-x
  77. 77. Foster AJ, Weinhold F. Natural hybrid orbitals. Journal of the American Chemical Society. 1980;102:7211-7218
  78. 78. Glendening ED, Badenhoop JK, Reed AE, Carpenter JE, Bohmann JA, Morales CM, et al. NBO Version 3.1. Madison: University of Wisconsin; 1998. p. 65
  79. 79. Mariappan G, Sundaraganesan N, Manoharan S. Experimental and theoretical spectroscopic studies of anticancer drug rosmarinic acid using HF and density functional theory. Spectrochimica Acta A. 2012;97:340-351. DOI: 10.1016/j.saa.2012.06.011
  80. 80. Balachandran V, Janaki A, Nataraj A. Theoretical investigations on molecular structure, vibrational spectra, HOMO, LUMO, NBO analysis and hyperpolarizability calculations of thiophene-2-carbohydrazide. Spectrochimica Acta A. 2014;118:321-330. DOI: 10.1016/j.saa.2013.08.091
  81. 81. Szafran M, Komasa A, Bartoszak-Adamska E. Crytsal and molecular structure of 4-carboxypiperidinium chloride(4-piperidinecarboxylic acid hydrochloride). Journal of Molecular Structure. 2007;827:101-107. DOI: 10.1016/j.molstruc.2006.05.012
  82. 82. Gangadharan RP. Natural bond orbital (NBO) population analysis of 1-Azanapthalene-8-ol. Acta Physica Polonica A. 2014;125:18-22. DOI: 10.12693/APhysPolA.125.18
  83. 83. Bhuvaneswari R, Bharathi MD, Anbalagan G, Chakkaravarthi G, Murugesan KS. Molecular structure, vibrational spectroscopic (FT-IR, FTRaman), NBO, HOMO and LUMO analysis of morpholinium oxalate by density functional method. Journal of Molecular Structure. 2018;1173:188-195. DOI: 10.1016/j.molstruc.2018.06.109
  84. 84. Khalil A, Abdel S, Kh A. TD-DFT calculations, NBO analysis and electronic absorption spectra of some thiazolo [3,2-a] pyridine derivatives. Journal of Molecular Structure. 2017;1147:651-667. DOI: 10.1016/j.molstruc.2017.06.098
  85. 85. Ravikumar C, Huber Joe I, Jayakumar VS. Charge transfer interactions and nonlinear optical properties of push-pull chromophore benzaldehyde phenylhydrazone: A vibrational approach. Chemical Physics Letters. 2008;460:552-558. DOI: 10.1016/j.cplett.2008.06.047
  86. 86. Sundius T. Scaling of ab initio force fields by MOLVIB. Vibrational Spectroscopy. 2002;29:89-95. DOI: 10.1016/S0924-2031(01)00189-8
  87. 87. Mumit MA, Pal TK, Alam MA, Islam MAA, Paul S, Sheikh MC. DFT studies on vibrational and electronic spectra, HOMO-LUMO, MEP, HOMA, NBO and molecular docking analysis of benzyl-3-N-(2,4,5-trimethoxyphenylmethylene)hydrazine carbodithioate. Journal of Molecular Structure. 2020;1220:128715-128726. DOI: 10.1016/j.molstruc.2020.128715
  88. 88. Gunasekaran S, Kumaresan S, Arunbalaji R, Anand G, Srinivasan S. Density functional theory study of vibrational spectra and assignment of fundamental modes of dacarbazine. Journal of Chemical Sciences. 2008;120:315-324. DOI: 10.1007/s12039-008-0054-8
  89. 89. Mulliken RS. Electronic population analysis on LCAO-MO molecular wave functions. The Journal of Chemical Physics. 1955;23:1833-1840. DOI: 10.1063/1.1740588
  90. 90. Mathammal R, Monisha NR, Yasaswini S, Krishnakumar V. Molecular structure, vibrational analysis (FT-IR, FT-Raman), NMR, UV, NBO and HOMO–LUMO analysis of N,N-Diphenyl Formamide based on DFT calculations. Spectrochimica Acta A. 2015;139:521-532. DOI: 10.1016/j.saa.2014.11.057

Written By

A. Antony Muthu Prabhu

Submitted: 20 October 2021 Reviewed: 10 December 2021 Published: 13 July 2022